Skip To Main Content

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

When to treat

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2

Pooled analysis: Interventional and observational studies

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.1

Overview of cGvHD

Actors

Immunology mechanism

Effect of cGVHD

cGVHD criteria

Guidelines

What is Toujeo?

How to Use Toujeo®

Atopic dermatitis pathophysiology: type 2 inflammation & cytokines

Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.

Taming Diabetes: A Daily Challenge for Martin and His Family

Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.